Lysophosphatidylcholine Potentiates Antibacterial Activity of Polymyxin B.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 11 2020
Historique:
received: 25 06 2020
accepted: 20 09 2020
pubmed: 30 9 2020
medline: 18 5 2021
entrez: 29 9 2020
Statut: epublish

Résumé

Polymyxin B, used to treat infections caused by antibiotic-resistant Gram-negative bacteria, produces nephrotoxicity at its current dosage. We show that a combination of nonbactericidal concentration of this drug and lysophosphatidylcholine (LPC) potently inhibits growth of

Identifiants

pubmed: 32988824
pii: AAC.01337-20
doi: 10.1128/AAC.01337-20
pmc: PMC7674032
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Lysophosphatidylcholines 0
Polymyxin B J2VZ07J96K

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

BMC Microbiol. 2003 Aug 12;3:16
pubmed: 12911840
Antimicrob Agents Chemother. 2014 May;58(5):2740-6
pubmed: 24566187
J Bacteriol. 1996 Dec;178(23):6857-64
pubmed: 8955307
Nat Immunol. 2006 Jun;7(6):583-9
pubmed: 16648855
Future Microbiol. 2013 Jun;8(6):711-24
pubmed: 23701329
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4464-70
pubmed: 27161639
Clin Microbiol Rev. 2017 Apr;30(2):557-596
pubmed: 28275006
Pathog Glob Health. 2015;109(7):309-18
pubmed: 26343252
EMBO J. 1990 Dec;9(12):4027-36
pubmed: 2249663
J Immunol. 1997 Dec 1;159(11):5550-9
pubmed: 9548496
Antimicrob Agents Chemother. 2015 Jul;59(7):3920-4
pubmed: 25896698
Mol Microbiol. 2003 Oct;50(1):219-30
pubmed: 14507376
J Bacteriol. 1998 Feb;180(4):846-54
pubmed: 9473038
J Bacteriol. 2008 Oct;190(20):6636-45
pubmed: 18723621
Nature. 1992 Apr 23;356(6371):683-9
pubmed: 1349157
Microbiology (Reading). 2007 Sep;153(Pt 9):3162-3173
pubmed: 17768259
Nat Med. 2004 Feb;10(2):161-7
pubmed: 14716308
J Med Chem. 2010 Jun 24;53(12):4585-602
pubmed: 20334364
Front Cell Infect Microbiol. 2019 Jul 31;9:270
pubmed: 31428589
Sci Rep. 2018 Oct 19;8(1):15501
pubmed: 30341337
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6383-7
pubmed: 2548211

Auteurs

Jitender Yadav (J)

Hybridoma Laboratory, National Institute of Immunology, New Delhi, India.

Sana Ismaeel (S)

Hybridoma Laboratory, National Institute of Immunology, New Delhi, India.

Ayub Qadri (A)

Hybridoma Laboratory, National Institute of Immunology, New Delhi, India ayub@nii.ac.in.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH